|1.||Wald, David N: 3 articles (01/2014 - 06/2008)|
|2.||Tse, William: 3 articles (01/2014 - 06/2008)|
|3.||Zang, Shaolei: 2 articles (01/2014 - 06/2008)|
|4.||Ji, Chunyan: 1 article (01/2014)|
|5.||Ma, Daoxin: 1 article (01/2014)|
|6.||Shao, Na: 1 article (01/2014)|
|7.||Wang, Hongchun: 1 article (01/2014)|
|8.||Liu, Na: 1 article (01/2014)|
|9.||Zhang, Jingru: 1 article (01/2014)|
|10.||Li, Lan: 1 article (11/2009)|
|1.||Myeloid Leukemia (Leukemia, Myelocytic)
11/15/2009 - "This paper described the development and validation of a liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for the quantitative determination of 6-benzylthioinosine (6BT), a novel myeloid leukemia differentiation-inducing agent, in mouse and human plasma. "
06/01/2008 - "Identification of 6-benzylthioinosine as a myeloid leukemia differentiation-inducing compound."
|2.||Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
12/19/2005 - "These findings further advance the rationale for developing 6-benzylthioinosine analogues as selective therapeutic agents for the treatment of toxoplasmosis."
12/19/2005 - "Inhibitors of nucleoside transport in mammalian cells can selectively protect the host from the toxicity of toxic purine nucleosides that may be used in future combination therapy against toxoplasmosis or from metabolites of the 6-benzylthioinosine analogues that may be released by the destruction of infected cells. "